SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-067221
Filing Date
2019-03-07
Accepted
2019-03-07 16:16:33
Documents
3
Period of Report
2019-03-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d720153d8k.htm 8-K 19294
2 EX-99.1 d720153dex991.htm EX-99.1 53523
3 GRAPHIC g720153dsp1.jpg GRAPHIC 17931
  Complete submission text file 0001193125-19-067221.txt   98904
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38529 | Film No.: 19666051
SIC: 2834 Pharmaceutical Preparations